Related Experiment Videos
Fragile Xq27 in somatic cells derived from different tissues.
1Department of Clinical Genetics, University of Birmingham, Edgbaston, England.
American Journal of Medical Genetics
|February 1, 1991
Summary
Prenatal diagnosis identified fragile X syndrome in fetuses. The fragile X marker (fra-Xq27) was detected across multiple fetal tissues, indicating its presence in most somatic cells.
Area of Science:
- Genetics
- Prenatal Diagnosis
- Cell Biology
Background:
- Martin-Bell syndrome, also known as fragile X syndrome, is a genetic disorder.
- Prenatal diagnosis aims to identify genetic conditions before birth.
Purpose of the Study:
- To investigate the presence and distribution of the fragile X marker (fra-Xq27) in various fetal tissues following prenatal diagnosis.
Main Methods:
- Prenatal diagnosis was performed on Martin-Bell syndrome cases.
- Monolayer cultures were established from diverse fetal tissues (testis, lung, kidney, skin, ovary, muscle).
- The fragile X marker (fra-Xq27) was ascertained in these cell cultures.
Main Results:
- Fragile X syndrome was detected in 4 male and 2 female fetuses.
- The fra-Xq27 marker was successfully identified in cells derived from multiple somatic tissues.
- No strong correlation was observed between the level of the marker and tissue-specific involvement in syndrome manifestation.
- Marker detection was more influenced by culture conditions than cell type, with easier detection in lymphocytes.
Conclusions:
- The fragility of the X chromosome in fragile X syndrome appears to be present in most, if not all, somatic cells.
- Tissue-specific manifestation levels do not strongly correlate with the detected fra-Xq27 marker levels.
- Lymphocytes may offer an advantageous cell type for fra-Xq27 detection.